Erlotinib plus either pazopanib or placebo in patients with previously treated advanced non–small cell lung cancer: A randomized, placebo‐controlled phase 2 trial with correlated serum proteomic signatures
Spigel, David R., Burris, Howard A., Greco, F. Anthony, Shih, Kent C., Gian, Victor G., Lipman, Andrew J., Daniel, Davey B., Waterhouse, David M., Finney, Lindsey, Heymach, John V., Hainsworth, John D.
Published in Cancer (01.06.2018)
Published in Cancer (01.06.2018)
Get full text
Journal Article
Sorafenib and continued erlotinib or sorafenib alone in patients with advanced non-small cell lung cancer progressing on erlotinib: A randomized phase II study of the Sarah Cannon Research Institute (SCRI)
Spigel, David R., Rubin, Mark S., Gian, Victor G., Shipley, Dianna L., Burris, Howard A., Kosloff, Rebecca A., Shih, Kent C., Quinn, Raven, Greco, F. Anthony, Hainsworth, John D.
Published in Lung cancer (Amsterdam, Netherlands) (01.11.2017)
Published in Lung cancer (Amsterdam, Netherlands) (01.11.2017)
Get full text
Journal Article
Paclitaxel/carboplatin with or without sorafenib in the first‐line treatment of patients with stage III/IV epithelial ovarian cancer: a randomized phase II study of the Sarah Cannon Research Institute
Hainsworth, John D., Thompson, Dana S., Bismayer, John A., Gian, Victor G., Merritt, William M., Whorf, Robert C., Finney, Lindsey H., Dudley, B. Stephens
Published in Cancer medicine (Malden, MA) (01.05.2015)
Published in Cancer medicine (Malden, MA) (01.05.2015)
Get full text
Journal Article
Phase II trial of ixabepilone and carboplatin with or without bevacizumab in patients with previously untreated advanced non-small-cell lung cancer
Spigel, David R, Anthony Greco, F, Waterhouse, David M, Shipley, Dianna L, Zubkus, John D, Bury, Martin J, Webb, Charles D, Hart, Lowell L, Gian, Victor G, Infante, Jeffrey R, Burris, Howard A, Hainsworth, John D
Published in Lung cancer (Amsterdam, Netherlands) (01.10.2012)
Published in Lung cancer (Amsterdam, Netherlands) (01.10.2012)
Get full text
Journal Article
A Phase II Trial of Carboplatin and Weekly Topotecan in the First-Line Treatment of Patients with Extensive Stage Small Cell Lung Cancer
Spigel, David R., Hainsworth, John D., Gandhi, Jitendra G., Gian, Victor G., Peyton, James D., West-Osterfield, Kimberly, Clark, Bobby L., Vazquez, Elizabeth R., Jones, Suzanne F., Burris, Howard A., Greco, F. Anthony
Published in Journal of thoracic oncology (01.06.2010)
Published in Journal of thoracic oncology (01.06.2010)
Get full text
Journal Article
A phase I trial of protracted oral fixed‐dose temozolomide
Jones, Suzanne F., Greco, F. Anthony, Gian, Victor G., Miranda, Fernando T., Raefsky, Eric L., Hainsworth, John D., Willcutt, Noel T., Beschorner, Aurelia F., Kennerly, Glyndon, Burris, Howard A.
Published in Cancer (01.11.2005)
Published in Cancer (01.11.2005)
Get full text
Journal Article
Phase I. Trial of irinotecan and temozolomide in patients with solid tumors
Jones, Suzanne F, Gian, Victor G, Greco, F Anthony, Miranda, Fernando T, Shipley, Dianna L, Thompson, Dana S, Hainsworth, John D, Toomey, Mitchell A, Willcutt, Noel T, Burris, 3rd, Howard A
Published in Oncology (Williston Park, N.Y.) (01.05.2003)
Get more information
Published in Oncology (Williston Park, N.Y.) (01.05.2003)
Journal Article
Gefitinib in the treatment of advanced, refractory non-small-cell lung cancer: results in 124 patients
Hainsworth, John D, Mainwaring, Mark G, Thomas, Melodie, Porter, 3rd, Lester L, Gian, Victor G, Jones, Suzanne F, Greco, F Anthony
Published in Clinical lung cancer (01.05.2003)
Published in Clinical lung cancer (01.05.2003)
Get full text
Journal Article
Phase II study of FOLFOXIRI plus panitumumab (pmab) followed by evaluation for resection, in patients (pts) with metastatic KRAS wild-type colorectal cancer (mCRC) with liver metastases only
Zakari, Ahmed, Gian, Victor G., Meluch, Anthony Alan, Peyton, James D., Waterhouse, David Michael, Lipman, Andrew J., Boccia, Ralph V., Jones, Suzanne Fields, Bendell, Johanna C.
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
Paclitaxel/carboplatin with or without sorafenib in the first-line treatment of patients with stage III/IV epithelial ovarian cancer: A randomized phase II study of the Sarah Cannon Research Institute
Thompson, Dana Shelton, Dudley, B. Stephens, Bismayer, John A., Gian, Victor G., Merritt, William McIver, Whorf, Robert C., Burris, Howard A., Hainsworth, John D.
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
COL1A1 copy number alterations detected in array-based comparative genomic hybridization (aCGH) inmyeloproliferative neoplasms: Implications for molecular pathogenesis and targeted therapy
Savona, Michael R., Chandra, Pranil, Ma, Zeqiang, Liang, Shile, Cooper, R. Seth, Raefsky, Eric, Gian, Victor G., Hockett, Richard, Berdeja, Jesus G., Lennon, P. Alan
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article